Equities research analysts at StockNews.com started coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Free Report) in a report issued on Sunday. The firm set a “hold” rating on the stock ...

Verastem, Inc. (NASDAQ:VSTM – Get Free Report) has been given an average rating of “Buy” by the nine ratings firms that are ...